J. Fuks

发表

Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung

M. Egorin, N. Bachur, M. Colvin, 1981, Cancer Chemotherapy and Pharmacology.

Restaging laparotomy in the management of the non-Hodgkin lymphomas.

J. Aisner, P. Wiernik, J. Fuks, 1982, Medical and pediatric oncology.

Computed tomography of the chest in small cell lung cancer: potential new prognostic signs.

J. Aisner, J. Fuks, M. Whitacre, 1984, AJR. American journal of roentgenology.

Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds

S. Wadler, P. Wiernik, J. Fuks, 1986, Journal of clinical pharmacology.

Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma

H. Tanowitz, J. Dutcher, S. Marcus, 1990, Cancer.

Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.

M. Levitt, D. V. Van Echo, J. Aisner, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy.

D. V. Van Echo, J. Aisner, J. Fuks, 1986, Medical and pediatric oncology.

Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias

R. Portenoy, J. Kaplan, D. Pack, 1990, Journal of Neuro-Oncology.

Metastatic choriocarcinoma in a middle-aged man presenting as a right thigh mass with venous thrombosis

J. Dutcher, P. Wiernik, J. Fuks, 2003, Medical oncology.

Clostridium cadaveris bacteremia in the immunocompromised host.

P. Wiernik, J. Fuks, R. Gucalp, 1993, Medical and pediatric oncology.

Phase I and II Agents in Cancer Therapy: Two Cisplatin Analogues and High‐Dose Cisplatin in Hypertonic Saline or With Thiosulfate Protection

S. Wadler, S Wadler, P. Wiernik, 1987, Journal of clinical pharmacology.

Initial Observations on the Effects of Δ9‐Tetrahydrocannabinol on the Plasma Pharmacokinetics of Cyclophosphamide and Doxorubicin

P. Duffey, M. Egorin, N. Bachur, 1981, Journal of clinical pharmacology.

Phase II Trial of Infusional Cyclophosphamide, Idarubicin, and Etoposide in Poor Prognosis Non-Hodgkin’s Lymphoma

A. Negassa, J. Sparano, P. Wiernik, 2003 .

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.

A. Negassa, J. Sparano, P. Wiernik, 2003, American journal of clinical oncology.

Syndrome of Inappropriate Antidiuretic Hormone Secretion and Hyponatremia

S. Marcus, J. Fuks, 1987 .

Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma.

M. Levitt, D. V. Van Echo, J. Aisner, 1982, Cancer treatment reports.

Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).

D. Ettinger, J. Ruckdeschel, S. Phan, 2000, The cancer journal from Scientific American.

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma

M. Egorin, N. Bachur, J. Aisner, 2004, Cancer Chemotherapy and Pharmacology.

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.

D. V. Van Echo, J. Aisner, J. Fuks, 1985, Medical and pediatric oncology.

Treatment of advanced non-small cell lung cancer with bisantrene.

J. Aisner, C. Garbino, J. Fuks, 1983, Cancer treatment reports.